Differentiation syndrome in acute promyelocytic leukemia: pathogenesis and risk factors Síndrome da diferenciação na leucemia promielocítica aguda: patogênese e fatores de risco
Differentiation syndrome is a treatment complication which can occur in acute promyelocytic leukemia (APL) patients treated with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO), which is characterized by enhanced leukocyte transmigration. Several cellular and molecular mechanisms participat...
Main Authors: | Eduardo M. Rego, Bárbara A. A. Santana-Lemos, Mirela B. Tamarozzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-06-01
|
Series: | Revista Brasileira de Hematologia e Hemoterapia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800009 |
Similar Items
-
Uso del trióxido de arsénico (Arsenin ®) en el tratamiento de la leucemia promielocítica en recaída Use of arsenic trioxide (Arsenin ®) in the treatment of promyelocytic leukemia relapse
by: Carlos Hernández Padrón, et al.
Published: (2007-04-01) -
Tratamiento de la leucemia promielocítica con trióxido de arsenico y acido trans-retinoico
by: Carlos Hernández Padrón -
Diagnóstico molecular de la leucemia aguda promielocítica: Resultados preliminares Molecular diagnosis of acute promyelocytic leukemia: preliminary results
by: Gisela Martínez Antuña, et al.
Published: (2000-08-01) -
Trióxido de arsénico: una nueva luz en el tratamiento de la leucemia promielocítica Arsenic trioxide: a new light in the treatment of promyelocytic leukemia
by: Carlos Hernández Padrón, et al.
Published: (2008-08-01) -
Acerca del artículo Leucemia promielocítica aguda M3. Reporte de un caso clínico
by: David Garrido
Published: (2020-12-01)